Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Horizon Therapeutics Public Ltd Co | EVP, CFO | Ordinary Shares | 72.8K | $8.48M | $116.50 | Apr 20, 2022 | By Trust |
Horizon Therapeutics Public Ltd Co | EVP, CFO | Ordinary Shares | 66.7K | $7.77M | $116.50 | Apr 20, 2022 | By LLC |
Horizon Therapeutics Public Ltd Co | EVP, CFO | Ordinary Shares | 1.05K | $122K | $116.50 | Apr 20, 2022 | Direct |
Horizon Therapeutics Public Ltd Co | EVP, CFO | Stock Option (Right to Buy) | 36.4K | Apr 20, 2022 | Direct | ||
Reneo Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 17.5K | Jun 6, 2023 | Direct | ||
Sagimet Biosciences Inc. | Director | Stock Option (Right to Buy) | 9.28K | Jun 5, 2024 | Direct |